
Illumina ILMN
€ 109.53
0.5%
Quartalsbericht 2025-Q3
hinzugefügt 31.10.2025
Illumina Langfristiger Schuldenstrom 2011-2026 | ILMN
Langfristiger Schuldenstrom Jährlich Illumina
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 79 M | 86 M | 71 M | 51 M | - | 45 M | 1.11 B | 10 M | 74.9 M | - | 304 M | 29.3 M | 37 M | 312 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.11 B | 10 M | 184 M |
Langfristiger Schuldenstrom anderer Aktien in der Diagnostik & Forschung
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M | ||
|
Co-Diagnostics
CODX
|
662 K | $ 1.65 | -1.2 % | $ 2.19 M | ||
|
Aspira Women's Health
AWH
|
202 K | - | -6.19 % | $ 10.5 M | ||
|
Lantheus Holdings
LNTH
|
3.8 M | $ 84.11 | -0.26 % | $ 5.68 B | ||
|
Medpace Holdings
MEDP
|
23.2 M | $ 421.37 | 2.64 % | $ 12.2 B | ||
|
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | ||
|
Castle Biosciences
CSTL
|
1.66 M | $ 24.98 | 2.13 % | $ 694 M | ||
|
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | ||
|
Koninklijke Philips N.V.
PHG
|
241 M | $ 27.54 | 0.25 % | $ 20 B | ||
|
Check-Cap Ltd.
CHEK
|
264 K | - | - | $ 9.42 M | ||
|
Personalis
PSNL
|
7.7 M | $ 5.96 | -2.3 % | $ 353 M | ||
|
CareDx, Inc
CDNA
|
6.52 M | $ 21.85 | 2.92 % | $ 1.16 B | ||
|
Senseonics Holdings
SENS
|
496 K | $ 7.27 | 3.12 % | $ 303 M | ||
|
Soleno Therapeutics
SLNO
|
726 K | $ 52.75 | 0.06 % | $ 2.68 B | ||
|
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | ||
|
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
33.6 M | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
1.44 M | $ 15.6 | -4.35 % | $ 472 M | ||
|
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M | ||
|
Thermo Fisher Scientific
TMO
|
275 M | $ 468.04 | -0.36 % | $ 176 B | ||
|
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
57.7 M | $ 171.23 | 0.86 % | $ 8.49 B | ||
|
Twist Bioscience Corporation
TWST
|
13.8 M | $ 61.0 | 0.1 % | $ 3.65 B | ||
|
Guardant Health
GH
|
27.7 M | $ 88.5 | -0.46 % | $ 11.1 B | ||
|
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | ||
|
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | ||
|
Interpace Biosciences
IDXG
|
431 K | - | - | $ 8.54 M | ||
|
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K | ||
|
QIAGEN N.V.
QGEN
|
23.4 M | - | - | $ 10.6 B | ||
|
Neogen Corporation
NEOG
|
5.64 M | $ 9.45 | -0.94 % | $ 2.05 B | ||
|
Biomerica
BMRA
|
358 K | $ 2.18 | 1.87 % | $ 5.01 M | ||
|
National Research Corporation
NRC
|
451 K | $ 17.11 | -0.7 % | $ 383 M | ||
|
ICON Public Limited Company
ICLR
|
24.3 M | $ 103.21 | 1.02 % | $ 8.51 B | ||
|
Laboratory Corporation of America Holdings
LH
|
191 M | $ 263.43 | -0.14 % | $ 21.9 B | ||
|
Celcuity
CELC
|
54 K | $ 125.68 | 3.84 % | $ 5.88 B | ||
|
OpGen
OPGN
|
174 K | - | -16.95 % | $ 1.54 M | ||
|
NeoGenomics
NEO
|
4.78 M | $ 8.61 | 3.86 % | $ 1.1 B | ||
|
Myriad Genetics
MYGN
|
6.9 M | $ 4.83 | 1.05 % | $ 447 M | ||
|
Natera
NTRA
|
7.64 M | $ 204.46 | 0.35 % | $ 20.1 B | ||
|
Quest Diagnostics Incorporated
DGX
|
174 M | $ 196.63 | 0.18 % | $ 21.8 B | ||
|
Invitae Corporation
NVTA
|
14.6 M | - | - | $ 21.2 M |